Innovative Approaches for Nonprescription Drug Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 18, 2018
April 24, 2020
212b0dcc-7c8f-44f5-8fd2-1af604a50f9a
Related Documents
Establishing Impurity Specifications for Antibiotics
Guidance DocumentApril 20, 2026Center for Drug Evaluation and Research
Clinical Pharmacology Considerations for Peptide Drug Products
Guidance DocumentDecember 14, 2023Center for Drug Evaluation and Research
In Vitro Release Test Studies for Topical Drug Products Submitted in ANDAs
Guidance DocumentOctober 21, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.